The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Roberts M Scot since 2018.
This trader's CIK number is 1705905.
At the time of last reporting, Roberts M Scot was the Chief Scientific Officer of Altimmune, Inc.. (stock ticker symbol ALT).
Also see all insider trading activities at Altimmune, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ALT | 0 | $0 | 0 | $0 | 37,816 | $0 |
| 2024 | ALT | 0 | $0 | 0 | $0 | 23,216 | $0 |
| 2023 | ALT | 0 | $0 | 0 | $0 | 13,941 | $0 |
| 2022 | ALT | 0 | $0 | 79,978 | $959,773 | 76,749 | $175,849 |
| 2018 | ALT | 449 | $1,984 | 0 | $0 | 55,120 | $4,409 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-01 | ALT | Option Ex | 6,166 | .00 | 0 |
| 2025-01-30 | ALT | Option Ex | 9,275 | .00 | 0 |
| 2025-02-02 | ALT | Option Ex | 7,775 | .00 | 0 |
| 2025-01-25 | ALT | Option Ex | 14,600 | .00 | 0 |
| 2024-02-01 | ALT | Option Ex | 6,166 | .00 | 0 |
| 2024-02-02 | ALT | Option Ex | 7,775 | .00 | 0 |
| 2024-01-30 | ALT | Option Ex | 9,275 | .00 | 0 |
| 2023-02-02 | ALT | Option Ex | 7,775 | .00 | 0 |
| 2023-02-01 | ALT | Option Ex | 6,166 | .00 | 0 |
| 2022-07-01 | ALT | Sale | 26,982 | 12.00 | 323,784 |
| 2022-07-05 | ALT | Option Ex | 787 | 2.95 | 2,321 |
| 2022-07-05 | ALT | Sale | 10,182 | 12.00 | 122,184 |
| 2022-07-01 | ALT | Option Ex | 26,982 | 2.77 | 74,875 |
| 2022-06-29 | ALT | Sale | 5,462 | 12.00 | 65,544 |
| 2022-06-29 | ALT | Option Ex | 5,462 | 2.60 | 14,201 |
| 2022-06-27 | ALT | Sale | 37,352 | 12.00 | 448,261 |
| 2022-06-27 | ALT | Option Ex | 37,352 | 2.26 | 84,452 |
| 2022-02-01 | ALT | Option Ex | 6,166 | .00 | 0 |
| 2018-05-21 | ALT | Option Ex | 55,120 | .08 | 4,409 |
| 2017-06-06 | ALT | Buy | 449 | 4.42 | 1,984 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Roberts M Scot (Chief Scientific Officer of Altimmune, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.